Page last updated: 2024-12-06

tribenoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tribenoside: anti-inflammatory agent used in edema of extremities, varicose veins & phlebitis; minor descriptor (75-86); on-line & INDEX MEDICUS search GLYCOSIDES (75-86); RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID196122
CHEMBL ID3301681
CHEBI ID91780
SCHEMBL ID7192326
MeSH IDM0263401

Synonyms (61)

Synonym
tribenoside
BPBIO1_001295
ethyl-3,5,6-tri-o-benzyl-d-glucofuranoside
einecs 233-687-2
tbgf
ba 21401
d-glucofuranoside, ethyl 3,5,6-tris-o-(phenylmethyl)-
glucofuranoside, ethyl-3,5,6-tri-o-benzyl-, d-
tribenosido [inn-spanish]
glyvenal
bg-356
tribenzoside
tribenosidum [inn-latin]
glivenol
d-glucofuranoside, ethyl-3,5,6-tris-o-(phenylmethyl)-
ethyl 3,5,6-tri-o-benzyl-d-glucofuranoside
PRESTWICK3_001019
NCGC00179274-01
BSPBIO_001177
AB00514005
10310-32-4
(3r,4r,5r)-5-[(1r)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxyoxolan-3-ol
HMS2098K19
tribenosidum
tribenosido
21401-ba
tribenoside [usan:inn:ban:jan]
unii-z7n0y673nu
z7n0y673nu ,
BRD-A60294240-001-01-1
tribenoside [usan]
tribenoside [ep monograph]
hemocuron
tribenoside [mart.]
tribenoside [who-dd]
tribenoside [jan]
tribenoside [mi]
tribenoside [inn]
CHEMBL3301681
CCG-221019
AKOS022185031
SCHEMBL7192326
(3r,4r,5r)-4-(benzyloxy)-5-((r)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol
W-200685
SR-01000872695-1
sr-01000872695
(3r,4r,5r)-5-[(1r)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxy-3-oxolanol
CHEBI:91780
F20469
HMS3715K19
ethyl 3,5,6-tri-o-benzyl-d-glucofuranoside;ethyl 3,5,6-tri-o-benzyl-d-glucofuranoside
Q533119
DB13227
mfcd00801089
ba 2140
A896620
dsstox_cid_3697
EX-A4214
HY-108249
BS-25775
CS-0027714
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
glycosideA glycosyl compound resulting from the attachment of a glycosyl group to a non-acyl group RO-, RS-, RSe-, etc. The bond between the glycosyl group and the non-acyl group is called a glycosidic bond. By extension, the terms N-glycosides and C-glycosides are used as class names for glycosylamines and for compounds having a glycosyl group attached to a hydrocarbyl group respectively. These terms are misnomers and should not be used. The preferred terms are glycosylamines and C-glycosyl compounds, respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (47.62)18.7374
1990's2 (9.52)18.2507
2000's3 (14.29)29.6817
2010's4 (19.05)24.3611
2020's2 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (6.45%)5.53%
Reviews3 (9.68%)6.00%
Case Studies4 (12.90%)4.05%
Observational0 (0.00%)0.25%
Other22 (70.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Screening for Colorectal Cancer in Average and High Risk Iraqi Population: A Pilot Study [NCT04017845]Early Phase 1537 participants (Actual)Interventional2015-04-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]